High-dimensional flow cytometry (FCM) analysis of available RCC samples (males: 10, females: 10) was performed to validate the protein-level expression of inferred receptors and ligands on CD8+ T-cells (expressing CD45+CD3+CD8+, Additional file 2: Fig. S6A). This evidence concerns the gene PTPRC and renal cell carcinoma.